Posted on August 25, 2016 by kmgarber
Heart disease is the leading cause of death in the U.S. and has been for decades. In 2014, there were more than 614,000 deaths from heart disease. However, a look at the long term trend lines shows that the number of deaths from heart disease is a curve that went up in the 70s and 80s and then has been coming back down in more recent years. The inflection point was 1985 with over 770,000 deaths from heart disease.
Cancer deaths meanwhile have been steadily increasing in a more or less straight line fashion from about 210,000 in 1950 to nearly 600,000 in 2014. Cancer is the second leading cause of death and has now nearly caught up with heart disease.
As of the most recent year, 2014, there were 22 states in which cancer deaths have surpassed heart disease deaths. The statisticians who wrote this brief note that the “leading-cause crossover” between heart disease and cancer was expected for the nation as a whole sometime around 2010, but that there was an uptick in heart disease mortality that kept this from happening at that time.
Source: Heron, M., and Anderson, R.N. (2016, Aug.). Changes in the leading cause of death: Recent patterns in heart disease and cancer mortality. NCHS Data Brief, 254. Click here for free full text: http://www.cdc.gov/nchs/data/databriefs/db254.pdf Also, data tables here: http://www.cdc.gov/nchs/data/databriefs/db254_table.pdf#1 Posted by AHA Resource Center (312) 422-2050, email@example.com
Filed under: Population health, Posted by Kim Garber, Uncategorized | Tagged: Cancer deaths, Cancer mortality trends, Heart disease deaths, Heart disease mortality trends, Mortality statistics | Leave a comment »
Posted on August 23, 2016 by kmgarber
This is a nice two-page summary of current statistics related to the Medicare and Medicaid programs. It provides official federal government counts of people and money – the number of beneficiaries and persons served and a recap of national health expenditures. But WAIT! There’s more! I am excited to let you know of a count of the total number of providers by type in the U.S. How many total hospitals? How many hospitals of different types? How many skilled nursing facilities? Ambulatory surgery centers? Labs? And other types of providers. These are useful totals for business planners who are sizing the market for a new product, for example.
U.S. Centers for Medicare & Medicaid Services. (2016, July 7). Fast Facts. Click here for free full text: https://www.cms.gov/fastfacts/
For more indepth information: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Fast-Facts/ Posted by AHA Resource Center (312) 422-2050, firstname.lastname@example.org
Filed under: Ambulatory surgery, Hospitals, Medicaid, Medicare, Nursing facilities, Posted by Kim Garber | Tagged: Ambulatory surgery center counts, Centers for Medicare & Medicaid Services, CMS fast facts, Hospital counts, Medicaid statistics, Medicare statistics, National health expenditures, Nursing home counts | Leave a comment »
Posted on August 18, 2016 by kmgarber
In this study of over 2 million adult cancer survivors, 8 percent were found to have later acquired a second, unrelated type of cancer. Those patients who had bladder cancer or non-Hodgkin lymphoma originally were found to be more likely to have a second cancer, which was most often lung cancer. An argument is made for more routine CT scans of the lungs of bladder cancer survivors as long-term follow-up.
[Interview with author]: Irwin, K. (2016, July 13). Nearly 1 in 12 patients with a common cancer develop a second, unrelated malignancy. UCLA Press Release. Full text free here: http://newsroom.ucla.edu/releases/nearly-1-in-12-patients-with-a-common-cancer-develop-a-second-unrelated-malignancy
[The medical journal article]: Dorin, N., Filson, C., Drakaki, A., and others. (2016, June). Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. Click here for access to publisher’s website: http://onlinelibrary.wiley.com/doi/10.1002/cncr.30164/abstract Posted by AHA Resource Center (312) 422-2050, email@example.com
Filed under: Imaging, Posted by Kim Garber | Tagged: Cancer care, Cancer incidence, Cancer statistics, Oncology care, Second cancers | Leave a comment »
Posted on August 11, 2016 by kmgarber
In 2015, 48 percent of employees in the private sector were enrolled in employer-sponsored health insurance, according to data from the federal government’s Medical Expenditure Panel Survey (MEPS). This percentage has been dropping in a straight-line fashion since 2008 (the earliest year in this data source), when 54 percent were enrolled. Not surprisingly, the data show that employees in large firms are much more likely to be enrolled in employer-sponsored health insurance than those in small firms. However, regardless of the size of the firm, the data from 2008 to 2015 show a decrease.
What do I like about this article?
- Authoritative government agency data source (MEPS is a survey conducted by the Agency for Healthcare Research and Quality – AHRQ)
- Free full text document
- Data plus narrative explanation of trends
Source: Miller, G.W., Vistnes, J., and Keenan, P. (2016, July). Results from the 2015 MEPS-IC private-sector national tables. Statistical Brief, 492, 5. Click here for free full text: https://meps.ahrq.gov/data_files/publications/st492/stat492.pdf Posted by AHA Resource Center (312) 422-2050, firstname.lastname@example.org
Filed under: Insurance, Posted by Kim Garber | Tagged: Employer sponsored health insurance statistics, Employer sponsored health insurance trends | Leave a comment »
Posted on August 5, 2016 by kmgarber
The federal government funded the Comprehensive Unit-based Safety Program (CUSP), a multi-year, nationwide effort to decrease the rate of urinary tract infection associated with the use of catheters in hospitalized patients. This project was under the leadership of AHA’s Health Research & Educational Trust (HRET). The project involved disseminating information and tool kits about best practices and collecting data. Data from over 600 hospitals were studied; these findings represent part of the hospitals that participated. It was found that hospital units that were not ICUs benefited from the program – as evidenced by a reduced UTI infection rate – but ICUs did not.
Reductions occurred mainly in non-ICUs, where catheter-associated UTI rates decreased from 2.28 to 1.54 infections per 1000 catheter-days…”
Source: Saint, S., and others. (2016, June 2). A program to prevent catheter-associated urinary tract infection in acute care. The New England Journal of Medicine, 374(22), 2111-2119. Click here for free full text: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1504906 Posted by AHA Resource Center (312)422-2050, email@example.com
Filed under: Benchmarking, Best practices, Patient safety, Posted by Kim Garber | Tagged: Agency for Healthcare Research and Quality, AHRQ, Catheter-associated urinary tract infections, Comprehensive Unit-based Safety Program (CUSP), Health Research & Educational Trust, healthcare acquired infections, hospital acquired conditions, Nosocomial infections, UTIs | Leave a comment »
Posted on August 1, 2016 by kmgarber
Immunotherapy is a way to activate a cancer patient’s own immune system to kill cancer cells through drug therapy. It has proved wildly successful with some types of advanced cancers – skin, Hodgkin’s lymphoma, lung, kidney, and bladder – shrinking tumors (so that they may become operable) or even eliminating tumors. President Jimmy Carter is perhaps the most famous success story, having been treated with surgery, radiation therapy, and the immunotherapy drug Keytruda, which has now become popularly known as the “Jimmy Carter drug.”
Researchers are not yet sure why immunotherapy works with some patients and not others, with some types of cancer and not others. Nor are they sure yet how long to continue to administer immunotherapy. The Grady article is a major story in the New York Times and the first in a series on immunotherapy. The Fox article provides additional information about a clinical trial of Keytruda in the treatment of lung cancer, which was found to be so effective that the trial was halted so that the control patients could also benefit by it.
Grady, D. (2016, July 31). A sickened body as cancer weapon. The New York Times, 165(57310), 1, 20-22. Click here: http://www.nytimes.com/images/2016/07/31/nytfrontpage/scannat.pdf
Fox, M. (2016, June 16). Lung cancer trial stopped after Jimmy Carter drug shrinks tumors. NBC News. Click here: http://www.nbcnews.com/health/cancer/lung-cancer-trial-stopped-after-jimmy-carter-drug-stops-tumors-n593726 Posted by AHA Resource Center (312) 422-2050, firstname.lastname@example.org
Filed under: Pharmaceuticals, Posted by Kim Garber | Tagged: Cancer care, Cancer drugs, Cancer treatment, Immunotherapy, Keytruda, Oncology drugs, Oncology treatment | Leave a comment »